跳至主要内容
临床试验/CTRI/2025/09/094375
CTRI/2025/09/094375尚未招募2 期

Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia laciniosa) churna in the manegement of PCOS

Dr D Y Patil College of Ayurved Hospital Pimpari Pune2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年9月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
140
试验地点
2
主要终点
Regularisation of menstrual cycle

研究概览

简要总结

“RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF THE SHIVLINGI BEEJA (BRYONIA LACINIOSA ) CHURNAINTHE MANEGEMENT OF PCOS.”

Introduction:

PCOS is one of the most common reproductive endocrinological disorder with a broad spectrum of clinical manifestations affecting 8 to 10%1.2 in reproductive age group. In PCOS ovaries fail to develops a mature egg and generate only multiple immature follicles with increase in ovarian size represented by oligomenorrhoea or amenorrhea, hyperandrogenism (Clinical Or Biochemical) and polycystic ovaries in USG which is diagnosed by Rotterdam Criteria (2003)3. The pathogenesis of PCOS is still largely unknown and until now medical care of these subjects has been limited to symptomatic control of cosmetic concerns, menstrual dysfunctions and infertility. Women with the syndrome are frequently insulin resistant, independent of obesity14. In these regards, much of the data supports that insulin resistance and the associated hyperinsulinemia plays an important role in PCOS. Insulin has direct effect on ovarian steroidogenesis stimulating androgen synthesis in theca cells leading to the syndrome7,15.

In Ayurvedic classics, PCOS maybe consider under various headings as Artavakshaya, Anartava, Nashtartava, Granthibhoota Artavdushti, Vandhyatva Yonivyapada, and Santarpanottha strotodushti. Pushpaghni Jataharini described in Kashyapa Samhita Khilsthana is the entity which is found more resembling with symptoms of PCOSamongst the others5.

Pushpaghni represents with typical features that includes destruction of Pushpa withregular menstruation, appearance of facial hair and obesity9.

PCOS can be considered as a condition manifested due to Mithyachara, Pradushtartava Beeja Dosha4.It may be term as Vata Kaphaja artva dushti.It is a Santarpanottha vikara withSanga, Avarana and Siragranthi form of pathogenesis. As the pathogenic factors involved in PCOS are Vata and Kapha Doshas Rasa and Meda – Dushyas, Artavavaha Strotas, Jatharagni and Dhatvagnimandya and will needVatakaphaghna and Rasayan Chikitsa as one of theway for sampraptibhanga.

Currently the standard care treatment for women with PCOS ranges from lifestyle modifications to pharmacological interventions including Anti androgens (Spironolactone, Flutamide), Insulin lowering agents (Metformin, Thiazolidine)8 and Oral Contraceptives as a single or combined17. Though effective, they do not abolish the basic problem and treatment is also associated with various adverse effects such as irregular menstruation, gastrointestinal disturbances, weight gain.

Considering all above points from various research papers found that “Shivlingi beeja” working on male as well as female infertility. Scientific research need was expressed by various authors in their review articles. As per data present role of Shivlingi beeja was studied on male rats, which shows good results. Every paper says it works on females also but such research is not done. As per tribes of Pakalkot these seeds are to be use in females those wants to concive.10 So it has been decided to work on Shivlingi beeja. According to Ayurvedic texts Shivlingi beeja has properties like uterine tonic, Rasayana, anti-obesity and antidiabetic properties. So with the hypothesis on the basis of available literature, Herbal or Herbomineral medicines according to Ayurveda can have great benefit in PCOS to abolish basic problem without or minimal adverse effect of conventional drugs. So it is decided to study the effect of the Shivlingi beeja (bryonia laciniosa ) churna in PCOS.

  Purpose of the study:

Purposeof present study is to Study theefficacy ofShivlingi beeja churna vatiin patients with PCOS.

 Expected duration of study and expected number of participants:

140 participants and each participant will be studied for 3 months.

Sr.No.

 Group A

Group B

|1.

Drug

Shivlingi beeja churna

Tab. Metformin

|2.

Dose

3 gms OD

Luke warm water

500 mg OD

|3.

Kala

Pragbhakta

Pragbhakta

|4.

Duration of therapy

3 months

3 months

|5.

Route of Administration

Oral

Oral

|6.

Follow up

Monthly

Monthly

Criteria of Assessment:

Assessment will be done based on following criteria before and after the treatment.

 Subjective criteria:

Menstrual cycle:

Interval between 2 cycles.

|Hirsutism19,20,21:

Modified Ferrimen and Galley Visual Scoring System*

Objective

Sr.Insulin(F)7,14,15

|BSL(F)14

|Insulin  Resistance

|Sr.Testesterone7,14,15

|PCOS Pattern and Ovarian Volume

|BMI (kg/m2 )18

Observational criteria:

1: Grading for interval between two menstrual cycles 2: Assessment of Hirsutism with Modified Ferriman and Galley Visual Scoring System19. 3: Assessment of variable BMI(Kg/m2)18 4: For Variable Sr. Insulin(F) 5: For variable Sr. Testesterone 6: For Variable BSL(F) 7: For Variable Ovarian Volume 8: For PCOS Pattern (Present or Absent)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • Married Unmarried Both.
  • PCOS diagnosed by Rotterdam crieteria 2/3.

排除标准

  • Patients showing signs and symptoms other than PCOS Patients having any other disease causing Oligomenorrhea and Anovulation excluding PCOS on above criteria i.e. Hypogonadotrophic Hypogonadism, Premature Ovarian Failure.
  • Patients suffering from a) Congenital Adrenal Hyperplasia b) Severe Insulin resistance (Insulin dependent Diabetes Mellitus) c) Androgen secreting Ovarian and Adrenal tumors d) Thyroid abnormalities e) Cushing’s syndrome f) Cardiac disease g) Hyperprolactemia.
  • Patients with any organic lesions of Reproductive Tract like TB, Ca, Congenital anomalies, any other pelvic pathologies.
  • A current or previous (within 3 months) use of OC Pills, Glucocorticoids, Antiandrogens, Antidiabetics, Antiobesity drugs or any Hormonal Therapy.

结局指标

主要结局

Regularisation of menstrual cycle

时间窗: Regularisation of menstrual cycle after 90 days

次要结局

  • effect of Shivlingi beeja churna on Insulin resistance(Sr Inshulin levels)
  • Change in BMI(BMI calculated)

研究者

发起方
Dr D Y Patil College of Ayurved Hospital Pimpari Pune
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

VD PRASHANT DALVI

Associate Professor, R A Podar Medical College AYU,

研究点 (2)

Loading locations...

相似试验